Literature DB >> 24785883

Predictors of in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction in patients with a high Killip class.

Jun Shiraishi1, Yoshio Kohno, Takeshi Nakamura, Takashi Yanagiuchi, Sho Hashimoto, Daisuke Ito, Masayoshi Kimura, Akihiro Matsui, Hirokazu Yokoi, Masayasu Arihara, Masayuki Hyogo, Takatomo Shima, Takahisa Sawada, Satoaki Matoba, Hiroyuki Yamada, Akiyoshi Matsumuro, Takeshi Shirayama, Makoto Kitamura, Keizo Furukawa.   

Abstract

OBJECTIVE: The predictors of in-hospital outcomes after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) complicated with heart failure or cardiogenic shock at presentation remain unclear.
METHODS: Using the AMI-Kyoto Multi-Center Risk Study database, the clinical background characteristics, angiographic findings, primary PCI results, and in-hospital prognoses were retrospectively compared between primary PCI-treated AMI patients with a Killip class status of ≥2 (Killip 2-4 patients, n=390) and those with a Killip class 1 status (Killip 1 patients, n=1,057).
RESULTS: The Killip 2-4 patients were more likely to have a higher age and proportion of women and exhibited a higher prevalence of previous myocardial infarction, diabetes mellitus and chronic kidney disease or anemia on admission, lower systolic blood pressure (SBP) values on admission, a higher rate of multivessels or left main trunk as the culprit artery, a larger number of diseased vessels, a lower Thrombolysis In Myocardial Infarction (TIMI) grade in the infarct-related artery (IRA) before/after primary PCI and a significantly higher in-hospital mortality rate than the Killip 1 patients. According to a multivariate analysis, age was found to be an independent positive predictor of in-hospital mortality, while admission SBP was an independent positive predictor of in-hospital survival in both groups. In contrast, anemia on admission was found to be an independent predictor of in-hospital death, while the TIMI 3 flow in the IRA after PCI was found to be an independent factor for survival in the Killip 2-4 patients, but not the Killip 1 patients.
CONCLUSION: Anemia on admission and the final TIMI 3 flow in the IRA are critical determinants of in-hospital death in AMI patients with a Killip class status of ≥2 undergoing primary PCI.

Entities:  

Mesh:

Year:  2014        PMID: 24785883     DOI: 10.2169/internalmedicine.53.1144

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Predictors of in-Hospital Mortality of ST-Segment Elevation Myocardial Infarction Patients Undergoing Interventional Treatment. An Analysis of Data from the RO-STEMI Registry.

Authors:  Diana E Cretu; Cristian A Udroiu; Claudiu I Stoicescu; Gabriel Tatu-Chitoiu; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2015-09

2.  Risk Factors of Mortality among Male Patients with Cardiovascular Disease in Malaysia Using Bayesian Analysis.

Authors:  Nurliyana Juhan; Yong Zulina Zubairi; Zarina Mohd Khalid; Ahmad Syadi Mahmood Zuhdi
Journal:  Iran J Public Health       Date:  2020-09       Impact factor: 1.429

3.  Association between total ischemic time and in-hospital mortality after emergency PCI in patients with acute ST-segment elevation myocardial infarction: a retrospective study.

Authors:  Nan Gao; Xiaoyong Qi; Yi Dang; Yingxiao Li; Gang Wang; Xiao Liu; Ning Zhu; Jinguo Fu
Journal:  BMC Cardiovasc Disord       Date:  2022-03-04       Impact factor: 2.298

4.  Development of Deep Learning Models for Predicting In-Hospital Mortality Using an Administrative Claims Database: Retrospective Cohort Study.

Authors:  Hiroki Matsui; Hayato Yamana; Kiyohide Fushimi; Hideo Yasunaga
Journal:  JMIR Med Inform       Date:  2022-02-11

5.  Predictors of Mortality in Patients with ST-Segment Elevation Acute Myocardial Infarction and Resuscitated Out-of-Hospital Cardiac Arrest.

Authors:  Andreea Bărcan; Monica Chițu; Edvin Benedek; Nora Rat; Szilamer Korodi; Mirabela Morariu; Istvan Kovacs
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.